Severe necrotizing pancreatitis following combined hepatitis A and B vaccination

CMAJ. Canadian Medical Association Journal

Volumn 176, Issue 3, 2007, Pages 339-342

  Shlomovitz, Eran ^a,c   Davies, Ward ^b   Cairns, Ewa ^b   Brintnell, William C ^b   Goldszmidt, Mark ^b   Dresser, George K ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; LEUKOCYTE ANTIGEN;

ACUTE HEMORRHAGIC PANCREATITIS; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE SEVERITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MALE; PHYSICAL EXAMINATION;

EID: 33846954029     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.060360     Document Type: Article

References (30)

1. Mishra A, Saigal S, Gupta R, et al. Acute pancreatitis associated with viral hepatitis: a report of six cases with review of literature. Am J Gastroenterol 1999;94:2292-5.
2. Hohenberger P. [The pancreas as target organ for hepatitis B virus - immunohistological detection of HBsAg in pancreatic carcinoma and chronic pancreatitis]. Leber Magen Darm 1985;15:58-63.
3. Sarles H, Sarles JC, Muratore R, et al. Chronic inflammatory sclerosis of the pancreas - An autonomous pancreatic disease? Am J Dig Dis 1961;6:688-98.
4. Sahel J, Barthet M, Gasmi M. Autoimmune pancreatitis: increasing evidence for a clinical entity with various patterns. Eur J Gastroenterol Hepatol 2004;16:1265-8.
5. Haviv YS, Sharkia M, Galun E, et al. Pancreatitis following hepatitis A vaccination. Eur J Med Res 2000;5:229-30.
6. Feldman G, Zer M. Infantile acute pancreatitis after mumps vaccination simulating an acute abdomen. Pediatr Surg Int 2000;16:488-9.
7. Adler JB, Mazzotta SA, Barkin JS. Pancreatitis caused by measles, mumps, and rubella vaccine. Pancreas 1991;6:489-90.
8. Gatt DT. Pancreatitis following monovalent typhoid and cholera vaccinations. Br J Clin Pract 1986;40:300-1.
9. Janigan DT, Nevalainen TJ, MacAulay MA, et al. Foreign serum-induced pancreatitis in mice. I. A new model of acute pancreatitis. Lab Invest 1975;33:591-607.
10. Marshall E. A shadow falls on hepatitis B vaccination effort. Science 1998;281:630-1.
11. Hogenesch H, Azcona-Olivera J, Scott-Moncrieff C, et al. Vaccine-induced autoimmunity in the dog. Adv Vet Med 1999;41:733-47.
12. Murphy-Ullrich JE, Oberley TD, Mosher DF. Detection of autoantibodies and glomerular injury in rabbits immunized with denatured human fibronectin monomer. Am J Pathol 1984;117:1-11.
13. Abrahamson DR, Caulfield JP. Proteinuria and structural alterations in rat glomerular basement membranes induced by intravenously injected anti-laminin immunoglobulin G. J Exp Med 1982;156:128-45.
14. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity - "vaccinosis": A dangerous liaison? J Autoimmun 2000;14:1-10.
15. Geier MR, Geier DA. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol 2004;22:749-55.
16. Pope JE, Stevens A, Howson W, et al. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 1998;25:1687-93.
17. Miller JD, Whitehair LH. Concurrent HLA-related response factors mediate recombinant hepatitis B vaccine major adverse events. Autoimmunity 2005;38:181-94.
18. Mineta M, Tanimura M, Tana T, et al. Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans. Int Immunol 1996;8:525-31.
19. Forbes A, Schwarz G, Mirakian R, et al. HLA antigens in chronic pancreatitis. Tissue Antigens 1987;30:176-83.
20. Schuenke KW, Cook RG, Rich RR. Binding specificity of a class II-restricted hepatitis B epitope by DR molecules from responder and nonresponder vaccine recipients. Hum Immunol 1998;59:783-93.
21. Abraham B, Parenti D. Antibody production in response to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. J Infect Dis 2000;182:1005-6.
22. Greub G, Genton B, Safary A, et al. Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix. Vaccine 2000;19:1113-7.
23. Abraham B, Baine Y, De-Clercq N, et al. Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine. Antiviral Res 2002;53:63-73.
24. Joines RW, Blatter M, Abraham B, et al. A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults. Vaccine 2001;19:4710-9.
25. Murdoch DL, Goa K, Figgitt DP. Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability. Drugs 2003;63:2625-49.
26. Van Damme P, Van Herck K. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine. Expert Rev Vaccines 2004;3:249-67.
27. Nothdurft HD, Dietrich M, Zuckerman JN, et al. A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine 2002;20:1157-62.
28. Nothdurft HD, Dietrich M, Zuckerman JN, et al. Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines. BioDrugs 2003;17(Suppl 1):15-8.
29. Averhoff F, Mahoney F, Coleman P, et al. Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998;15:1-8.
30. Stoffel M, Lievens M, Dieussaert I, et al. Immunogenicity of Twinrix in older adults: a critical analysis. Expert Rev Vaccines 2003;2:9-14.